Search research articles
Contact Us
Filters
Showing results (381-390 of 511) with videos related to
Page
of 52
Sort By:
British Journal of Cancer
|
May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells
Jenni Nikkilä, Rahul Kumar, James Campbell, et al.
Journal of the National Cancer Institute
|
August 16, 2011
Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer
Chee K Lee, Michael Friedlander, Chris Brown, et al.
Molecular Oncology
|
October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7
Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
<i>De novo</i> designed bright, hyperstable rhodamine binders for fluorescence microscopy
Yuda Chen, Klaus Yserentant, Kibeom Hong, et al.
Oncotarget
|
June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
David King, Xiao Dun Li, Gilberto S Almeida, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
FEBS Letters
|
February 23, 2026
Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposium
Ludovica Proietti, Pedro Beltrao, Alejandra Bruna, et al.
Pigment Cell & Melanoma Research
|
May 15, 2012
Genomic characterisation of acral melanoma cell lines
Simon J Furney, Samra Turajlic, Kerry Fenwick, et al.
Genome Biology
|
October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing
David Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Cancer Research
|
November 19, 2013
Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity
Ilirjana Bajrami, Jessica R Frankum, Asha Konde, et al.
Page
of 52
Search research articles
Search
Showing results (381-390 of 511) with videos related to
Sort By:
Page
of 52
British Journal of Cancer
|
May 24, 2017
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells
Jenni Nikkilä, Rahul Kumar, James Campbell, et al.
Journal of the National Cancer Institute
|
August 16, 2011
Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer
Chee K Lee, Michael Friedlander, Chris Brown, et al.
Molecular Oncology
|
October 22, 2023
Cancer-associated FBXW7 loss is synthetic lethal with pharmacological targeting of CDC7
Joseph S Baxter, Rachel Brough, Dragomir B Krastev, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
<i>De novo</i> designed bright, hyperstable rhodamine binders for fluorescence microscopy
Yuda Chen, Klaus Yserentant, Kibeom Hong, et al.
Oncotarget
|
June 25, 2020
MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma
David King, Xiao Dun Li, Gilberto S Almeida, et al.
Gut
|
August 24, 2017
Mapping genetic vulnerabilities reveals BTK as a novel therapeutic target in oesophageal cancer
Irene Yushing Chong, Lauren Aronson, Hanna Bryant, et al.
FEBS Letters
|
February 23, 2026
Genetic interactions, synthetic lethality and complexity in cancer vulnerability mapping-Insights and perspectives from the 2nd EuroDepMap symposium
Ludovica Proietti, Pedro Beltrao, Alejandra Bruna, et al.
Pigment Cell & Melanoma Research
|
May 15, 2012
Genomic characterisation of acral melanoma cell lines
Simon J Furney, Samra Turajlic, Kerry Fenwick, et al.
Genome Biology
|
October 25, 2011
High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing
David Sims, Ana M Mendes-Pereira, Jessica Frankum, et al.
Cancer Research
|
November 19, 2013
Genome-wide profiling of genetic synthetic lethality identifies CDK12 as a novel determinant of PARP1/2 inhibitor sensitivity
Ilirjana Bajrami, Jessica R Frankum, Asha Konde, et al.
Page
of 52